Monoclonal antibodies have emerged as a promising approach in the fight against Alzheimer’s disease, offering hope for slowing its progression. These laboratory-produced molecules are designed to ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

I’m really annoyed, on behalf of the journalist Charles Piller, about the release date of his book “ Doctored: Fraud, ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to families and caregivers.

A MUM-of-two was accused of taking cocaine and told she had dementia in her thirties – but she was being slowly poisoned by her poorly fitted boiler. Sue Westwood-Ruttledge battled constant ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

In an exclusive TV interview with "CBS Mornings," the mother of Stephen "tWitch" Boss talks about the recent release of the ...